Explore the categories so you can find more about your search.

Categorie > Immune System / Vaccines

Biovest Announces Strategy For Seeking Early Approval Of Its Anti-Cancer Vaccine For Non-Hodgkins Lymphoma

Categorie : Immune System / Vaccines
Biovest International, Inc. (OTCBB:BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced its regulatory strategy for its Fast Tracked Phase 3 clinical trial of its anti-cancer vaccine for the treatment of Non-Hodgkin's Lymphoma, BiovaxID. The trial w ...

read more Biovest International, Inc. (OTCBB:BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced its regulatory strategy for its Fast Tracked Phase 3 clinical trial of its anti-cancer vaccine for the treatment of Non-Hodgkin's Lymphoma, BiovaxID. The trial w read more Sun Oct 2007 Sun Oct 2007

Stanford Researchers Seek Volunteers For Malaria Vaccine Study

Categorie : Immune System / Vaccines
Seeing children in Africa die from cerebral malaria made a lasting impression on pediatric infectious disease specialist Sharon Fei-Hsien Chen, MD. While serving in Uganda and Kenya several years ago, she often saw parents bring a sick child to the hospital only to find out that nothing could sa ...

read more Seeing children in Africa die from cerebral malaria made a lasting impression on pediatric infectious disease specialist Sharon Fei-Hsien Chen, MD. While serving in Uganda and Kenya several years ago, she often saw parents bring a sick child to the hospital only to find out that nothing could sa read more Sun Oct 2007 Sun Oct 2007

Malaria Vaccine Trial On Babies Shows Promising Results

Categorie : Immune System / Vaccines
An early stage trial carried out in Africa of a malaria vaccine already shown to be effective in adults has suggested it is safe and even more effective for young babies, setting the stage for larger scale final phase trials.The study is published in the early online edition of The Lancet and was th ...

read more An early stage trial carried out in Africa of a malaria vaccine already shown to be effective in adults has suggested it is safe and even more effective for young babies, setting the stage for larger scale final phase trials.The study is published in the early online edition of The Lancet and was th read more Sun Oct 2007 Sun Oct 2007

Study Finds Immune Cells Fighting Chronic Infections Become Progressively 'Exhausted,' Ineffective

Categorie : Immune System / Vaccines
A new study of immune cells battling a chronic viral infection shows that the cells, called T cells, become exhausted by the fight in specific ways, undergoing profound changes that make them progressively less effective over time.The findings also point to interventions that would reverse the chang ...

read more A new study of immune cells battling a chronic viral infection shows that the cells, called T cells, become exhausted by the fight in specific ways, undergoing profound changes that make them progressively less effective over time.The findings also point to interventions that would reverse the chang read more Sun Oct 2007 Sun Oct 2007

2007-08 Adult Immunization Schedule Endorsed By Internists And Published In Annals Of Internal Medicine

Categorie : Immune System / Vaccines
The American College of Physicians (ACP), with membership of 124,000 internal medicine physicians (internists), related subspecialists, and medical students, endorses the Centers for Disease Control's (CDC) adult immunization schedule for 2007-2008 and published the recommendations on the Web si ...

read more The American College of Physicians (ACP), with membership of 124,000 internal medicine physicians (internists), related subspecialists, and medical students, endorses the Centers for Disease Control's (CDC) adult immunization schedule for 2007-2008 and published the recommendations on the Web si read more Sun Oct 2007 Sun Oct 2007

Enzyme Synergy Shown To Perpetuate Sleeping Sickness

Categorie : Immune System / Vaccines
The pathogenesis of the parasite African trypanosome (T. brucei) has been linked to a key protein switch, detailed in a new study by researchers at the University of Iowa and the Veterans Affairs Medical Center of Iowa City, led by Dr. John Donelson. The study, published in PLoS Pathogens, e ...

read more The pathogenesis of the parasite African trypanosome (T. brucei) has been linked to a key protein switch, detailed in a new study by researchers at the University of Iowa and the Veterans Affairs Medical Center of Iowa City, led by Dr. John Donelson. The study, published in PLoS Pathogens, e read more Sun Oct 2007 Sun Oct 2007

Ubiquitin Builds Up An Immune Response

Categorie : Immune System / Vaccines
The acquired immune response is triggered after specific engagement of foreign peptides (antigens) by receptor molecules on white blood cell (lymphocytes). Cellular signaling pathways are responsible for the activation of lymphocytes. Krappmann and co-workers present evidence, that in T cells, w ...

read more The acquired immune response is triggered after specific engagement of foreign peptides (antigens) by receptor molecules on white blood cell (lymphocytes). Cellular signaling pathways are responsible for the activation of lymphocytes. Krappmann and co-workers present evidence, that in T cells, w read more Sun Oct 2007 Sun Oct 2007

FDA Expands Age Range For Use Of Bacterial Meningitis Vaccine

Categorie : Immune System / Vaccines
The U.S. Food and Drug Administration expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years. Meningitis is a serious inflammation of the lining that surrounds the spinal cord and brain. It can result in death or permanent injury to the b ...

read more The U.S. Food and Drug Administration expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years. Meningitis is a serious inflammation of the lining that surrounds the spinal cord and brain. It can result in death or permanent injury to the b read more Sun Oct 2007 Sun Oct 2007

New Lancet Study: Malaria Vaccine Candidate Has Promising Safety, Tolerability Profile In Infants

Categorie : Immune System / Vaccines
The first study to test GlaxoSmithKline's (GSK) investigational RTS,S/AS02 malaria vaccine in African infants serves as the first proof of concept in this population that the vaccine has a promising safety and tolerability profile and reduces malaria parasite infection and clinical illness due to ma ...

read more The first study to test GlaxoSmithKline's (GSK) investigational RTS,S/AS02 malaria vaccine in African infants serves as the first proof of concept in this population that the vaccine has a promising safety and tolerability profile and reduces malaria parasite infection and clinical illness due to ma read more Sun Oct 2007 Sun Oct 2007

'Oscars Of Invention' Honour UTMB Researchers Who Created Artificial Immune System

Categorie : Immune System / Vaccines
Two University of Texas Medical Branch at Galveston (UTMB) researchers who pioneered the development of an artificial immune system that mimics that of the human body and will allow researchers to speed the development of vaccines were honored at a showcase known as "the Oscars of invention" held at ...

read more Two University of Texas Medical Branch at Galveston (UTMB) researchers who pioneered the development of an artificial immune system that mimics that of the human body and will allow researchers to speed the development of vaccines were honored at a showcase known as read more Sun Oct 2007 Sun Oct 2007

Novel Vaccine For Aggressive Brain Tumors Tested By Mayo Clinic

Categorie : Immune System / Vaccines
A vaccine that has significantly increased life expectancy in early tests of patients with glioblastoma multiforme (GBM) -- the most common, most aggressive form of brain cancer in adults -- is now being offered through a clinical trial at Mayo Clinic in Jacksonville.The vaccine repr ...

read more A vaccine that has significantly increased life expectancy in early tests of patients with glioblastoma multiforme (GBM) -- the most common, most aggressive form of brain cancer in adults -- is now being offered through a clinical trial at Mayo Clinic in Jacksonville.The vaccine repr read more Sun Oct 2007 Sun Oct 2007

Deadly Brain Tumors May Respond To Treatment Using Common Virus

Categorie : Immune System / Vaccines
A common human virus may prove useful in attacking the deadliest form of brain tumors, according to a study by researchers at Duke's Preston Robert Tisch Brain Tumor Center. The researchers said the finding is an important step in developing a vaccine that can attack the tumors by enlisting the help ...

read more A common human virus may prove useful in attacking the deadliest form of brain tumors, according to a study by researchers at Duke's Preston Robert Tisch Brain Tumor Center. The researchers said the finding is an important step in developing a vaccine that can attack the tumors by enlisting the help read more Sun Oct 2007 Sun Oct 2007

Collaboration To Create Comprehensive Model Of Immune Responses, Funded By NIAID $51M Contract

Categorie : Immune System / Vaccines
A team of scientists is expanding efforts to develop a detailed picture of immune system function with a new $51 million, five-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The research builds on a project origina ...

read more A team of scientists is expanding efforts to develop a detailed picture of immune system function with a new $51 million, five-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The research builds on a project origina read more Sun Oct 2007 Sun Oct 2007

Government Of Madagascar And Coalition Of Global Partners Launch Measles And Malaria Prevention Campaign

Categorie : Immune System / Vaccines
The government of Madagascar, in collaboration with international partners, is launching a national health campaign to vaccinate more than 2.8 million children against measles and distribute more than 1.5 million insecticide-treated mosquito nets to prevent the spread of malaria-diseases whi ...

read more The government of Madagascar, in collaboration with international partners, is launching a national health campaign to vaccinate more than 2.8 million children against measles and distribute more than 1.5 million insecticide-treated mosquito nets to prevent the spread of malaria-diseases whi read more Sun Oct 2007 Sun Oct 2007

Direct Route From Brain To Immune System Discovered By Scientists

Categorie : Immune System / Vaccines
It used to be dogma that the brain was shut away from the actions of the immune system, shielded from the outside forces of nature. But that's not how it is at all. In fact, thanks to the scientific detective work of Kevin Tracey, MD, it turns out that the brain talks directly to the immune system, ...

read more It used to be dogma that the brain was shut away from the actions of the immune system, shielded from the outside forces of nature. But that's not how it is at all. In fact, thanks to the scientific detective work of Kevin Tracey, MD, it turns out that the brain talks directly to the immune system, read more Sun Oct 2007 Sun Oct 2007

Approval For UK Clinical Trial Announced By Oncolytics Biotech Inc.

Categorie : Immune System / Vaccines
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN&# ...

read more Oncolytics Biotech Inc. ( read more Sun Oct 2007 Sun Oct 2007

CERVARIX®, GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response In 100% Of Women Up To 55 Years Of Age

Categorie : Immune System / Vaccines
New Phase III data show that at 18 months after the first of a three-dose regimen, 100 percent of women up to age 55 vaccinated with the GlaxoSmithKline (GSK) cervical cancer candidate vaccine had antibodies present against the two most common cancer-causing human papillomavirus types, 16 and 18. [c ...

read more New Phase III data show that at 18 months after the first of a three-dose regimen, 100 percent of women up to age 55 vaccinated with the GlaxoSmithKline (GSK) cervical cancer candidate vaccine had antibodies present against the two most common cancer-causing human papillomavirus types, 16 and 18. [c read more Fri Jun 2007 Fri Jun 2007

High Efficacy For HPV Vaccine Shown By International Studies

Categorie : Immune System / Vaccines
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer - strains 16 and 18. Results of an international meta-analysis study of the vaccine are published in the June 1 issu ...

read more A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer - strains 16 and 18. Results of an international meta-analysis study of the vaccine are published in the June 1 issu read more Thu Jun 2007 Thu Jun 2007

HHS Buys Next Generation Smallpox Vaccine

Categorie : Immune System / Vaccines
HHS Secretary Mike Leavitt announced today that HHS has awarded a contract for 500 million dollars to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara (MVA) smallpox vaccine. The vaccine would be recommended in the e ...

read more HHS Secretary Mike Leavitt announced today that HHS has awarded a contract for 500 million dollars to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara (MVA) smallpox vaccine. The vaccine would be recommended in the e read more Thu Jun 2007 Thu Jun 2007

UK And Other European Countries Should Introduce Universal Childhood Hepatitis B Vaccination

Categorie : Immune System / Vaccines
Children in the UK and seven other European countries should be universally vaccinated against hepatitis B to eliminate the major public-health impact of this disease, according to a Review published in the June issue of The Lancet Infectious Diseases. Infection with hepatitis B causes between 500 ...

read more Children in the UK and seven other European countries should be universally vaccinated against hepatitis B to eliminate the major public-health impact of this disease, according to a Review published in the June issue of The Lancet Infectious Diseases. Infection with hepatitis B causes between 500 read more Thu Jun 2007 Thu Jun 2007

1 | 2 | 3 | 4 next >>>



     


Custom Search